Last updated on December 2018

A prostate cancer study that will evaluate safety and efficacy of niraparib in combination with other anti-cancer agents


Brief description of study

The purpose of this study is to see if niraparib, when used in combination with JNJ-6373283, is useful for treating patients with advanced prostate cancer.  The safety of niraparib when used is combination with JNJ-63723283 will also be studied.

 

Detailed Study Description

Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and patients can choose to withdraw from clinical trials at any time.

 

Clinical Study Identifier: TX217805

Contact Investigators or Research Sites near you

Start Over

Candice Fortuna

The Urology Center of Colorado
Denver, CO USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.